Physician

Rajan Goyal, M.D.

According to 2025 Medicare claims, Rajan Goyal, M.D. (NPI: 1063695658) practices pulmonary disease in the Bakersfield-Delano, CA market, with the plurality of this provider's patient population coming from Kern, CA. This provider's primary affiliated billing organization is RAJAN GOYAL MD INC (NPI: 1467188201; TIN: 882594259) and primary practice location at 93309-1667. Goyal is affiliated with the Collaborative ACO 30, LLC (ACO ID: A5483), participating under the MSSP model.

Goyal's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 999 traditional Medicare patients, billed 5,575 HCPCS/CPT codes, and received $499,641 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 4,767 prescription claims across 851 beneficiaries totaling $1,789,747 in drug costs, led by Ofev (Nintedanib Esylate). DME data shows 2,871 claims. Open Payments data shows 74 records totaling $50,528. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $143,900 to $499,641. Similarly, Part D prescription costs have moved sharply higher in recent years, from $893,493 to $1,789,747. For DME billing, reported payments rose steadily, from $103,487 to $182,190.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	703	2,164	$143,900
2016	402	898	$54,445
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	75	296	$52,167
2021	223	824	$115,001
2022	612	2,349	$175,330
2023	720	3,312	$287,717
2024	999	5,575	$499,641

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	351	2,495	$893,493
2016	285	1,841	$892,133
2017	82	200	$223,223
2018	148	382	$244,305
2019	275	952	$572,663
2020	314	1,247	$618,389
2021	412	2,186	$1,212,449
2022	591	2,979	$1,268,127
2023	613	3,814	$1,711,956
2024	851	4,767	$1,789,747

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	66	415	$94,549
2016	63	509	$56,248
2017	15	362	$28,797
2018	29	374	$28,971
2019	125	334	$38,761
2020	363	1,179	$82,245
2021	428	1,570	$93,007
2022	522	1,779	$102,385
2023	607	2,285	$148,872
2024	934	2,871	$247,278

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	691	1,651	$143
94729	Test to examine how well the lungs exchange gases	580	590	$45
94726	Test to determine lung volumes using sensors	553	563	$45
94060	Test to measure expiratory airflow and volume changes before and after medication administration	570	581	$31
94200	Test to measure largest amount of air breathed in an out	521	530	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ofev	Nintedanib Esylate	64	1,920	$746,817
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	726	24,270	$490,098
Breo Ellipta	Fluticasone/Vilanterol	277	8,625	$107,730
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	131	4,288	$85,921
Ambrisentan	Ambrisentan	13	390	$52,345

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E0483	High frequency chest wall oscillation system, with full anterior and/or posterior thoracic region receiving simultaneous external oscillation, includes all accessories and supplies, each	Y	N/R	62	$59,607
J7699	Noc drugs, inhalation solution administered through dme	N	N/R	14	$45,182
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	85	614	$41,493
J7677	Revefenacin inhalation solution, fda-approved final product, non-compounded, administered through dme, 1 microgram	N	12	23	$17,485
E0466	Home ventilator, any type, used with non-invasive interface, (e.g., mask, chest shell)	Y	N/R	15	$12,873

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	71	$1,635	GlaxoSmithKline, LLC.
Research Payments	Reported research-related payment or transfer-of-value amount.	3	$48,894	Galvanize Therapeutics, Inc
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Rajan Goyal, M.D.?

Tedicare shows public-source Medicare data for Rajan Goyal, M.D. (NPI 1063695658), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Rajan Goyal, M.D. have ACO affiliation data?

Rajan Goyal, M.D. is shown with ACO affiliation data for Collaborative ACO 30, LLC (MSSP, ACO ID A5483).

What billing organization is linked to Rajan Goyal, M.D.?

Rajan Goyal, M.D. is linked to RAJAN GOYAL MD INC (billing NPI 1467188201) in the available physician profile data.

Does Rajan Goyal, M.D. have Open Payments data?

Rajan Goyal, M.D. has 74 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.